Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue.
Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue. Clin Cancer Res. 2004 Jun 01; 10(11):3881-4.